1. Home
  2. NBTX
  3. NBTX News

Latest Nanobiotix S.A. (NBTX) News on November 19, 2025

NBTX

MT Newswires

19 days ago

Nanobiotix to Receive Up to $71 Million in Royalty Financing From HealthCare Royalty

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth
NBTX

GlobeNewswire

19 days ago

NANOBIOTIX Announces Strategic Royalty Monetization Agreement With Healthcare Royalty for up to $71 Million and Extends Cash Runway Toward Long-Term Growth

NBTX

MT Newswires

22 days ago

Top Premarket Gainers

NBTX

MT Newswires

23 days ago

Top Premarket Decliners

This Stock Is Up 440% in a Year. Is It an Undiscovered Star or a Flash in the Pan?
NBTX

Barchart

a month ago

This Stock Is Up 440% in a Year. Is It an Undiscovered Star or a Flash in the Pan?

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

5 months ago

Voting Rights and Shares Capital of the Company

NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference
NBTX

GlobeNewswire

6 months ago

NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference

Nanobiotix Provides First Quarter 2025 Operational and Financial Update
NBTX

GlobeNewswire

6 months ago

Nanobiotix Provides First Quarter 2025 Operational and Financial Update

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

6 months ago

Voting Rights and Shares Capital of the Company

Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
NBTX

GlobeNewswire

6 months ago

Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ

Nanobiotix presents outcomes from trial of JNJ-1900 for pancreatic cancer
NBTX

Clinical Trials Arena

6 months ago

Nanobiotix presents outcomes from trial of JNJ-1900 for pancreatic cancer

NBTX

MT Newswires

6 months ago

Nanobiotix Says Potential Pancreatic Cancer Treatment Extends Survival in Phase 1 Study

Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
NBTX

GlobeNewswire

6 months ago

Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer

Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer Followed by a Conference Call
NBTX

GlobeNewswire

7 months ago

Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer Followed by a Conference Call

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

7 months ago

Voting Rights and Shares Capital of the Company

Nanobiotix SA (NBTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
NBTX

GuruFocus.com

7 months ago

Nanobiotix SA (NBTX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges

NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
NBTX

GlobeNewswire

8 months ago

NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results

NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
NBTX

GlobeNewswire

8 months ago

NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025

Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC
NBTX

GlobeNewswire

8 months ago

Nanobiotix Announces First Data From the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients With Locally Advanced NSCLC

NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
NBTX

GlobeNewswire

8 months ago

NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference

NBTX

MT Newswires

8 months ago

Nanobiotix Amends Licensing Deal With Johnson & Johnson

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
NBTX

GlobeNewswire

8 months ago

NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

8 months ago

Voting Rights and Shares Capital of the Company

Is Nanobiotix (NBTX) the Best Nanotech Penny Stock to Invest In?
NBTX

Insider Monkey

9 months ago

Is Nanobiotix (NBTX) the Best Nanotech Penny Stock to Invest In?

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

9 months ago

Voting Rights and Shares Capital of the Company

Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025
NBTX

GlobeNewswire

10 months ago

Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study
NBTX

Zacks

10 months ago

Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study

NBTX

MT Newswires

10 months ago

Sector Update: Health Care Stocks Rise Premarket Tuesday

NBTX

MT Newswires

10 months ago

Nanobiotix Doses First Patient in Phase 2 Study of Lung Cancer Therapy

NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer
NBTX

GlobeNewswire

10 months ago

NANOBIOTIX Announces First Patient Dosed in a New Randomized Phase 2 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Stage 3 Unresectable Non-Small Cell Lung Cancer

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

10 months ago

Voting Rights and Shares Capital of the Company

NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
NBTX

GlobeNewswire

a year ago

NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

a year ago

Voting Rights and Shares Capital of the Company

NBTX

MT Newswires

a year ago

Nanobiotix's NBTXR3 Phase 1 Study Yields Promising Results for Pancreatic Cancer Treatment

NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
NBTX

GlobeNewswire

a year ago

NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

a year ago

Voting Rights and Shares Capital of the Company

NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
NBTX

GlobeNewswire

a year ago

NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms

NANOBIOTIX to Participate in Multiple Investor Conferences in November
NBTX

GlobeNewswire

a year ago

NANOBIOTIX to Participate in Multiple Investor Conferences in November

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

a year ago

Voting Rights and Shares Capital of the Company

NBTX

MT Newswires

a year ago

Nanobiotix H1 Loss Narrows, Revenue Rises

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
NBTX

GlobeNewswire

a year ago

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results

NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
NBTX

GlobeNewswire

a year ago

NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth

Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
NBTX

GlobeNewswire

a year ago

Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference

NBTX

MT Newswires

a year ago

--Guggenheim Initiates Nanobiotix at Buy

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

a year ago

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

a year ago

Voting Rights and Shares Capital of the Company

NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
NBTX

GlobeNewswire

a year ago

NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

a year ago

Voting Rights and Shares Capital of the Company

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook
NBTX

GuruFocus.com

a year ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

NBTX

Energy Global

a year ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings
NBTX

USA TODAY

a year ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management
NBTX

Business Wire

a year ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins
NBTX

Business Wire

a year ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

SEALSQ to Launch Two New Quantum Resistant Chips
NBTX

GlobeNewswire

a year ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll
NBTX

Reuters

a year ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030
NBTX

GlobeNewswire

a year ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
NBTX

GlobeNewswire

a year ago

Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
NBTX

GlobeNewswire

a year ago

NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
NBTX

GlobeNewswire

a year ago

NANOBIOTIX to Present at the Jefferies Global Healthcare Conference

NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
NBTX

GlobeNewswire

a year ago

NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update

NBTX

MT Newswires

a year ago

Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship

Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
NBTX

GlobeNewswire

a year ago

Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

2 years ago

Voting Rights and Shares Capital of the Company

NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
NBTX

GlobeNewswire

2 years ago

NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024

NBTX

MT Newswires

2 years ago

Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment

NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
NBTX

GlobeNewswire

2 years ago

NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer

NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
NBTX

GlobeNewswire

2 years ago

NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results

NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
NBTX

GlobeNewswire

2 years ago

NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024

11 Best Nanotechnology Stocks To Invest In
NBTX

Insider Monkey

2 years ago

11 Best Nanotechnology Stocks To Invest In

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

2 years ago

Voting Rights and Shares Capital of the Company

Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
NBTX

GlobeNewswire

2 years ago

Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation

Nanobiotix to Present at Upcoming Investor Conferences in March
NBTX

GlobeNewswire

2 years ago

Nanobiotix to Present at Upcoming Investor Conferences in March

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

2 years ago

Voting Rights and Shares Capital of the Company

Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
NBTX

GlobeNewswire

2 years ago

Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference

Baillie Gifford Bolsters Stake in Nanobiotix SA
NBTX

GuruFocus.com

2 years ago

Baillie Gifford Bolsters Stake in Nanobiotix SA

Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study
NBTX

GlobeNewswire

2 years ago

Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study

Americans' monthly debt payments surge since the pandemic
NBTX

Fox Business

2 years ago

Americans' monthly debt payments surge since the pandemic

Delaware Court of Chancery Rules in Favor of Whitestone
NBTX

GlobeNewswire

2 years ago

Delaware Court of Chancery Rules in Favor of Whitestone

Kearny Financial Corp (KRNY) Faces Net Loss in Q2 Fiscal 2024 Amid Strategic Repositioning
NBTX

GuruFocus.com

2 years ago

Kearny Financial Corp (KRNY) Faces Net Loss in Q2 Fiscal 2024 Amid Strategic Repositioning

NBTX

GlobeNewswire

2 years ago

WEYCO Group, Inc. Fourth Quarter and Full Year 2023 Earnings Conference Call

Hawaiian Airlines Boosts Summer Schedule
NBTX

PR Newswire

2 years ago

Hawaiian Airlines Boosts Summer Schedule

S&P 500 Sell-Off? 1 Spectacular Stock to Buy Hand Over Fist and 1 to Sell
NBTX

Motley Fool

2 years ago

S&P 500 Sell-Off? 1 Spectacular Stock to Buy Hand Over Fist and 1 to Sell

Stitch Fix (SFIX) Fortifies With AI Amid Market Challenges
NBTX

Zacks

2 years ago

Stitch Fix (SFIX) Fortifies With AI Amid Market Challenges

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024
NBTX

PR Newswire

2 years ago

Cohen & Steers Announces Retirement of William Scapell, Head of Fixed Income and Preferred Securities, Effective August 1, 2024

Limbach's (LMB) Stock Skyrockets 32% in 3 Months: Here's How
NBTX

Zacks

2 years ago

Limbach's (LMB) Stock Skyrockets 32% in 3 Months: Here's How

Voting Rights and Shares Capital of the Company
NBTX

GlobeNewswire

2 years ago

Voting Rights and Shares Capital of the Company

NBTX

Business Wire

2 years ago

BlackRock Closed-End Funds have Repurchased approximately $1.3 Billion of Shares since the Share Repurchase Program’s Inception

Peapack-Gladstone Bank Appoints Rich Johnston as President, Peapack Capital, a Subsidiary of Peapack-Gladstone Bank
NBTX

NewMediaWire

2 years ago

Peapack-Gladstone Bank Appoints Rich Johnston as President, Peapack Capital, a Subsidiary of Peapack-Gladstone Bank

Ezcorp (EZPW) Exceeds Market Returns: Some Facts to Consider
NBTX

Zacks

2 years ago

Ezcorp (EZPW) Exceeds Market Returns: Some Facts to Consider

Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2023 Update
NBTX

GlobeNewswire

2 years ago

Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2023 Update

Gladstone Investment Announces Monthly Cash Distributions for January, February and March 2024, and Earnings Release and Conference Call Dates for the Third Fiscal Quarter
NBTX

ACCESSWIRE

2 years ago

Gladstone Investment Announces Monthly Cash Distributions for January, February and March 2024, and Earnings Release and Conference Call Dates for the Third Fiscal Quarter

Tuya to Participate in Fireside Chat Series at the CES 2024
NBTX

PR Newswire

2 years ago

Tuya to Participate in Fireside Chat Series at the CES 2024

National CineMedia, U.S. Representative for Cannes Lions International Festival of Creativity, Launches the 2024 Young Lions Competition
NBTX

Business Wire

2 years ago

National CineMedia, U.S. Representative for Cannes Lions International Festival of Creativity, Launches the 2024 Young Lions Competition

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
NBTX

GlobeNewswire

2 years ago

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

Here's Why You Should Add Olympic Steel (ZEUS) to Your Portfolio
NBTX

Zacks

2 years ago

Here's Why You Should Add Olympic Steel (ZEUS) to Your Portfolio

Enliven Therapeutics Inc CFO Benjamin Hohl Sells 11,870 Shares
NBTX

GuruFocus.com

2 years ago

Enliven Therapeutics Inc CFO Benjamin Hohl Sells 11,870 Shares

NBTX

Business Wire

2 years ago

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

16 Most Profitable Small-Cap Stocks Now
NBTX

Insider Monkey

2 years ago

16 Most Profitable Small-Cap Stocks Now

Bear of the Day: Marriott Vacations (VAC)
NBTX

Zacks

2 years ago

Bear of the Day: Marriott Vacations (VAC)

JinkoSolar is the First PV Company Worldwide with Net-zero Targets Approved by the Science Based Targets initiative
NBTX

PR Newswire

2 years ago

JinkoSolar is the First PV Company Worldwide with Net-zero Targets Approved by the Science Based Targets initiative

Share on Social Networks: